000			01882 a2200577 4500
005			20250517215137.0
264		0	_c20190906
008			201909s 0 0 eng d
022			_a1365-2893
024	7		_a10.1111/jvh.12932 _2doi
040			_aNLM _beng _cNLM
100	1		_aJeong, Y
245	0	0	_aEvolution and persistence of resistance-associated substitutions of hepatitis C virus after direct-acting antiviral treatment failures. _h[electronic resource]
260			_bJournal of viral hepatitis _c11 2018
300			_a1251-1259 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aCarbamates
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Resistance, Viral _xgenetics
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xtherapeutic use
650	0	4	_aIsoquinolines _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aPyrrolidines
650	0	4	_aRNA, Viral _xbiosynthesis
650	0	4	_aSulfonamides _xtherapeutic use
650	0	4	_aTreatment Failure
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aViral Nonstructural Proteins _xgenetics
650	0	4	_aVirus Assembly _xgenetics
650	0	4	_aVirus Replication _xgenetics
700	1		_aJin, B
700	1		_aLee, H W
700	1		_aPark, H J
700	1		_aPark, J Y
700	1		_aKim, D Y
700	1		_aHan, K-H
700	1		_aAhn, S H
700	1		_aKim, S
773	0		_tJournal of viral hepatitis _gvol. 25 _gno. 11 _gp. 1251-1259
856	4	0	_uhttps://doi.org/10.1111/jvh.12932 _zAvailable from publisher's website
999			_c28398462 _d28398462